Defective control of pre-messenger RNA splicing in human disease

Journal of Cell Biology

Volumn 212, Issue 1, 2016, Pages 13-27

  Chabot, Benoit ^a   Shkreta, Lulzim ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA PRECURSOR; MYC PROTEIN; PROTEIN; SF3B1 PROTEIN; U2AF1 PROTEIN; UNCLASSIFIED DRUG; ZRSR2 PROTEIN; MESSENGER RNA; RNA BINDING PROTEIN;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FRONTOTEMPORAL DEMENTIA; GENE CONTROL; GENE DISRUPTION; HEART DISEASE; HUMAN; HUNTINGTON CHOREA; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR PATHOLOGY; MUSCLE DISEASE; MYELODYSPLASTIC SYNDROME; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SPLICING; SCHIZOPHRENIA; SPINAL MUSCULAR ATROPHY; SPLICEOSOME; TUMOR PROMOTION; GENETICS; METABOLISM; NEOPLASM;

HUMANS; MYELODYSPLASTIC SYNDROMES; NEOPLASMS; NEUROPATHOLOGY; RNA SPLICING; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84974615755     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201510032     Document Type: Review

References (174)

1. Adesso, L., S. Calabretta, F. Barbagallo, G. Capurso, E. Pilozzi, R. Geremia, G. Delle Fave, and C. Sette. 2013. Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. Oncogene. 32:2848-2857. http://dx.doi.org/10.1038/onc.2012.306
2. Adler, A.S., M.L. McCleland, S. Yee, M. Yaylaoglu, S. Hussain, E. Cosino, G. Quinones, Z. Modrusan, S. Seshagiri, E. Torres, et al. 2014. An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth. Genes Dev. 28:1068-1084. http://dx.doi.org/10.1101/gad.237206.113
3. Alló, M., V. Buggiano, J.P. Fededa, E. Petrillo, I. Schor, M. de la Mata, E. Agirre, M. Plass, E. Eyras, S.A. Elela, et al. 2009. Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat. Struct. Mol. Biol. 16:717-724. http://dx.doi.org/10.1038/nsmb.1620
4. Ameyar-Zazoua, M., C. Rachez, M. Souidi, P. Robin, L. Fritsch, R. Young, N. Morozova, R. Fenouil, N. Descostes, J.C. Andrau, et al. 2012. Argonaute proteins couple chromatin silencing to alternative splicing. Nat. Struct. Mol. Biol. 19:998-1004. http://dx.doi.org/10.1038/nsmb.2373
5. Anczuków, O., A.Z. Rosenberg, M. Akerman, S. Das, L. Zhan, R. Karni, S.K. Muthuswamy, and A.R. Krainer. 2012. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat. Struct. Mol. Biol. 19:220-228. http://dx.doi.org/10.1038/nsmb.2207
6. Anczuków, O., M. Akerman, A. Clery, J. Wu, C. Shen, N.H. Shirole, A. Raimer, S. Sun, M.A. Jensen, Y. Hua, et al. 2015. SRSF1-regulated alternative splicing in breast cancer. Mol. Cell. 60:105-117. http://dx.doi.org/10.1016/j.molcel.2015.09.005
7. Arnold, E.S., S.C. Ling, S.C. Huelga, C. Lagier-Tourenne, M. Polymenidou, D. Ditsworth, H.B. Kordasiewicz, M. McAlonis-Downes, O. Platoshyn, P.A. Parone, et al. 2013. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. USA. 110:E736-E745. http://dx.doi.org/10.1073/pnas.1222809110
8. Babic, I., E.S. Anderson, K. Tanaka, D. Guo, K. Masui, B. Li, S. Zhu, Y. Gu, G.R. Villa, D. Akhavan, et al. 2013. EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. Cell Metab. 17:1000-1008. http://dx.doi.org/10.1016/j.cmet.2013.04.013
9. Bai, B., C.M. Hales, P.C. Chen, Y. Gozal, E.B. Dammer, J.J. Fritz, X. Wang, Q. Xia, D.M. Duong, C. Street, et al. 2013. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 110:16562-16567. http://dx.doi.org/10.1073/pnas.1310249110
10. Barash, Y., J.A. Calarco, W. Gao, Q. Pan, X. Wang, O. Shai, B.J. Blencowe, and B.J. Frey. 2010. Deciphering the splicing code. Nature. 465:53-59. http://dx.doi.org/10.1038/nature09000
11. Barry, G., J.A. Briggs, D.P. Vanichkina, E.M. Poth, N.J. Beveridge, V.S. Ratnu, S.P. Nayler, K. Nones, J. Hu, T.W. Bredy, et al. 2014. The long noncoding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol. Psychiatry. 19:486-494. http://dx.doi.org/10.1038/mp.2013.45
12. Batra, R., K. Charizanis, M. Manchanda, A. Mohan, M. Li, D.J. Finn, M. Goodwin, C. Zhang, K. Sobczak, C.A. Thornton, and M.S. Swanson. 2014. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol. Cell. 56:311-322. http://dx.doi.org/10.1016/j.molcel.2014.08.027
13. Bentley, D.L. 2014. Coupling mRNA processing with transcription in time and space. Nat. Rev. Genet. 15:163-175. http://dx.doi.org/10.1038/nrg3662
14. Biamonti, G., M. Catillo, D. Pignataro, A. Montecucco, and C. Ghigna. 2014. The alternative splicing side of cancer. Semin. Cell Dev. Biol. 32:30-36. http://dx.doi.org/10.1016/j.semcdb.2014.03.016
15. Boultwood, J., H. Dolatshad, S.S. Varanasi, B.H. Yip, and A. Pellagatti. 2014. The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes. Adv. Biol. Regul. 54:153-161. http://dx.doi.org/10.1016/j.jbior.2013.09.005
16. Braeutigam, C., L. Rago, A. Rolke, L. Waldmeier, G. Christofori, and J. Winter. 2014. The RNA-binding protein Rbfox2: An essential regulator of EMTdriven alternative splicing and a mediator of cellular invasion. Oncogene. 33:1082-1092. http://dx.doi.org/10.1038/onc.2013.50
17. Brooks, A.N., P.S. Choi, L. de Waal, T. Sharifnia, M. Imielinski, G. Saksena, C.S. Pedamallu, A. Sivachenko, M. Rosenberg, J. Chmielecki, et al. 2014. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS One. 9:e87361. http://dx.doi.org/10.1371/journal.pone.0087361
18. Calabretta, S., P. Bielli, I. Passacantilli, E. Pilozzi, V. Fendrich, G. Capurso, G.D. Fave, and C. Sette. 2015. Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells. Oncogene. In press. http://dx.doi.org/10.1038/onc.2015.270
19. Charizanis, K., K.Y. Lee, R. Batra, M. Goodwin, C. Zhang, Y. Yuan, L. Shiue, M. Cline, M.M. Scotti, G. Xia, et al. 2012. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron. 75:437-450. http://dx.doi.org/10.1016/j.neuron.2012.05.029
20. Chasin, L.A. 2007. Searching for splicing motifs. Adv. Exp. Med. Biol. 623:85-106. http://dx.doi.org/10.1007/978-0-387-77374-26
21. Christofk, H.R., M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, R. Wei, M.D. Fleming, S.L. Schreiber, and L.C. Cantley. 2008. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 452:230-233. http://dx.doi.org/10.1038/nature06734
22. Cieply, B., and R.P. Carstens. 2015. Functional roles of alternative splicing factors in human disease. Wiley Interdiscip. Rev. RNA. 6:311-326. http://dx.doi.org/10.1002/wrna.1276
23. Coady, T.H., and J.L. Manley. 2015. ALS mutations in TLS/FUS disrupt target gene expression. Genes Dev. 29:1696-1706. http://dx.doi.org/10.1101/gad.267286.115
24. Cohen, O.S., T.W. Weickert, J.L. Hess, L.M. Paish, S.Y. McCoy, D.A. Rothmond, C. Galletly, D. Liu, D.D. Weinberg, X.F. Huang, et al. 2015. A splicingregulatory polymorphism in DRD2 disrupts ZRA NB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Mol. Psychiatry. In press. http://dx.doi.org/10.1038/mp.2015.137
25. Colla, S., D.S. Ong, Y. Ogoti, M. Marchesini, N.A. Mistry, K. Clise-Dwyer, S.A. Ang, P. Storti, A. Viale, N. Giuliani, et al. 2015. Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome. Cancer Cell. 27:644-657. http://dx.doi.org/10.1016/j.ccell.2015.04.007
26. Comiskey, D.F. Jr., A.G. Jacob, R.K. Singh, A.S. Tapia-Santos, and D.S. Chandler. 2015. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage. Nucleic Acids Res. 43:4202-4218. http://dx.doi.org/10.1093/nar/gkv223
27. Corominas, R., X. Yang, G.N. Lin, S. Kang, Y. Shen, L. Ghamsari, M. Broly, M. Rodriguez, S. Tam, S.A. Trigg, et al. 2014. Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism. Nat. Commun. 5:3650. http://dx.doi.org/10.1038/ncomms4650
28. Corrionero, A., B. Minana, and J. Valcarcel. 2011. Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes Dev. 25:445-459. http://dx.doi.org/10.1101/gad.2014311
29. Darnell, R.B. 2013. RNA protein interaction in neurons. Annu. Rev. Neurosci. 36:243-270. http://dx.doi.org/10.1146/annurev-neuro-062912-114322
30. Das, S., and A.R. Krainer. 2014. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol. Cancer Res. 12:1195-1204. http://dx.doi.org/10.1158/1541-7786.MCR-14-0131
31. David, C.J., M. Chen, M. Assanah, P. Canoll, and J.L. Manley. 2010. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 463:364-368. http://dx.doi.org/10.1038/nature08697
32. Davidson, L., A. Kerr, and S. West. 2012. Co-transcriptional degradation of aberrant pre-mRNA by Xrn2. EMBO J. 31:2566-2578. http://dx.doi.org/10.1038/emboj.2012.101
33. DeOcesano-Pereira, C., M.S. Amaral, K.S. Parreira, A.C. Ayupe, J.F. Jacysyn, G.P. Amarante-Mendes, E.M. Reis, and S. Verjovski-Almeida. 2014. Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis. Nucleic Acids Res. 42:8343-8355. http://dx.doi.org/10.1093/nar/gku561
34. Devlin, B., and S.W. Scherer. 2012. Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev. 22:229-237. http://dx.doi.org/10.1016/j.gde.2012.03.002
35. Di Modugno, F., L. Demonte, M. Balsamo, G. Bronzi, M.R. Nicotra, M. Alessio, E. Jager, J.S. Condeelis, A. Santoni, P.G. Natali, and P. Nistico. 2007. Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: Epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines. Cancer Res. 67:2657-2665. http://dx.doi.org/10.1158/0008-5472.CAN-06-1997
36. Dolatshad, H., A. Pellagatti, M. Fernandez-Mercado, B.H. Yip, L. Malcovati, M. Attwood, B. Przychodzen, N. Sahgal, A.A. Kanapin, H. Lockstone, et al. 2015. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia. 29:1092-1103. http://dx.doi.org/10.1038/leu.2014.331
37. Domínguez-Sánchez, M.S., S. Barroso, B. Gomez-Gonzalez, R. Luna, and A. Aguilera. 2011. Genome instability and transcription elongation impairment in human cells depleted of THO/TREX. PLoS Genet. 7:e1002386. http://dx.doi.org/10.1371/journal.pgen.1002386
38. Echeverria, G.V., and T.A. Cooper. 2012. RNA-binding proteins in microsatellite expansion disorders: Mediators of RNA toxicity. Brain Res. 1462:100-111. http://dx.doi.org/10.1016/j.brainres.2012.02.030
39. Fernández-Nogales, M., J.R. Cabrera, M. Santos-Galindo, J.J. Hoozemans, I. Ferrer, A.J. Rozemuller, F. Hernandez, J. Avila, and J.J. Lucas. 2014. Huntington's disease is a four-repeat tauopathy with tau nuclear rods. Nat. Med. 20:881-885. http://dx.doi.org/10.1038/nm.3617
40. Fogel, B.L., E. Wexler, A. Wahnich, T. Friedrich, C. Vijayendran, F. Gao, N. Parikshak, G. Konopka, and D.H. Geschwind. 2012. RBF OX1 regulates both splicing and transcriptional networks in human neuronal development. Hum. Mol. Genet. 21:4171-4186. http://dx.doi.org/10.1093/hmg/dds240
41. Fu, X.D., and M. Ares Jr. 2014. Context-dependent control of alternative splicing by RNA-binding proteins. Nat. Rev. Genet. 15:689-701. http://dx.doi.org/10.1038/nrg3778
42. Ge, K., J. DuHadaway, W. Du, M. Herlyn, U. Rodeck, and G.C. Prendergast. 1999. Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc. Natl. Acad. Sci. USA. 96:9689-9694. http://dx.doi.org/10.1073/pnas.96.17.9689
43. Gehman, L.T., P. Stoilov, J. Maguire, A. Damianov, C.H. Lin, L. Shiue, M. Ares Jr., I. Mody, and D.L. Black. 2011. The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nat. Genet. 43:706-711. http://dx.doi.org/10.1038/ng.841
44. Gehman, L.T., P. Meera, P. Stoilov, L. Shiue, J.E. O'Brien, M.H. Meisler, M. Ares Jr., T.S. Otis, and D.L. Black. 2012. The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. Genes Dev. 26:445-460. http://dx.doi.org/10.1101/gad.182477.111
45. Gentien, D., O. Kosmider, F. Nguyen-Khac, B. Albaud, A. Rapinat, A.G. Dumont, F. Damm, T. Popova, R. Marais, M. Fontenay, et al. 2014. A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages. Leukemia. 28:1355-1357. http://dx.doi.org/10.1038/leu.2014.28
46. Gerstberger, S., M. Hafner, and T. Tuschl. 2014. A census of human RNAbinding proteins. Nat. Rev. Genet. 15:829-845. http://dx.doi.org/10.1038/nrg3813
47. Gonzalez, I., R. Munita, E. Agirre, T.A. Dittmer, K. Gysling, T. Misteli, and R.F. Luco. 2015. A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature. Nat. Struct. Mol. Biol. 22:370-376.
48. Goodwin, M., A. Mohan, R. Batra, K.Y. Lee, K. Charizanis, F.J. Gomez, S. Eddarkaoui, N. Sergeant, L. Buee, T. Kimura, et al. 2015. MBNL sequestration by toxic RNAs and RNA misprocessing in the myotonic dystrophy brain. Cell Reports. 12:1159-1168. http://dx.doi.org/10.1016/j.celrep.2015.07.029
49. Graubert, T.A., D. Shen, L. Ding, T. Okeyo-Owuor, C.L. Lunn, J. Shao, K. Krysiak, C.C. Harris, D.C. Koboldt, D.E. Larson, et al. 2011. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat. Genet. 44:53-57. http://dx.doi.org/10.1038/ng.1031
50. Gretarsdottir, S., H. Helgason, A. Helgadottir, A. Sigurdsson, G. Thorleifsson, A. Magnusdottir, A. Oddsson, V. Steinthorsdottir, T. Rafnar, J. de Graaf, et al. 2015. A splice region variant in LDLR lowers non-high density lipoprotein cholesterol and protects against coronary artery disease. PLoS Genet. 11:e1005379. http://dx.doi.org/10.1371/journal.pgen.1005379
51. Guo, W., S. Schafer, M.L. Greaser, M.H. Radke, M. Liss, T. Govindarajan, H. Maatz, H. Schulz, S. Li, A.M. Parrish, et al. 2012. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat. Med. 18:766-773. http://dx.doi.org/10.1038/nm.2693
52. Gutschner, T., M. Hammerle, and S. Diederichs. 2013. MAL AT1-a paradigm for long noncoding RNA function in cancer. J. Mol. Med. 91:791-801. http://dx.doi.org/10.1007/s00109-013-1028-y
53. Hales, C.M., N.T. Seyfried, E.B. Dammer, D. Duong, H. Yi, M. Gearing, J.C. Troncoso, E.J. Mufson, M. Thambisetty, A.I. Levey, and J.J. Lah. 2014. U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21. Mol. Neurodegener. 9:15. http://dx.doi.org/10.1186/1750-1326-9-15
54. Herman, D.S., L. Lam, M.R. Taylor, L. Wang, P. Teekakirikul, D. Christodoulou, L. Conner, S.R. DePalma, B. McDonough, E. Sparks, et al. 2012. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366:619-628. http://dx.doi.org/10.1056/NEJMoa1110186
55. Highley, J.R., J. Kirby, J.A. Jansweijer, P.S. Webb, C.A. Hewamadduma, P.R. Heath, A. Higginbottom, R. Raman, L. Ferraiuolo, J. Cooper-Knock, et al. 2014. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol. Appl. Neurobiol. 40:670-685. http://dx.doi.org/10.1111/nan.12148
56. Hsu, T.Y., L.M. Simon, N.J. Neill, R. Marcotte, A. Sayad, C.S. Bland, G.V. Echeverria, T. Sun, S.J. Kurley, S. Tyagi, et al. 2015. The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature. 525:384-388. http://dx.doi.org/10.1038/nature14985
57. Hua, Y., Y.H. Liu, K. Sahashi, F. Rigo, C.F. Bennett, and A.R. Krainer. 2015. Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models. Genes Dev. 29:288-297. http://dx.doi.org/10.1101/gad.256644.114
58. Ilagan, J.O., A. Ramakrishnan, B. Hayes, M.E. Murphy, A.S. Zebari, P. Bradley, and R.K. Bradley. 2015. U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Res. 25:14-26. http://dx.doi.org/10.1101/gr.181016.114
59. Irimia, M., R.J. Weatheritt, J.D. Ellis, N.N. Parikshak, T. Gonatopoulos-Pournatzis, M. Babor, M. Quesnel-Vallieres, J. Tapial, B. Raj, D. O'Hanlon, et al. 2014. A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell. 159:1511-1523. http://dx.doi.org/10.1016/j.cell.2014.11.035
60. Ittner, L.M., and J. Gotz. 2011. Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12:65-72. http://dx.doi.org/10.1038/nrn2967
61. Janssens, J., and C. Van Broeckhoven. 2013. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum. Mol. Genet. 22(R1):R77-R87. http://dx.doi.org/10.1093/hmg/ddt349
62. Kandoth, C., M.D. McLellan, F. Vandin, K. Ye, B. Niu, C. Lu, M. Xie, Q. Zhang, J.F. McMichael, M.A. Wyczalkowski, et al. 2013. Mutational landscape and significance across 12 major cancer types. Nature. 502:333-339. http://dx.doi.org/10.1038/nature12634
63. Karni, R., E. de Stanchina, S.W. Lowe, R. Sinha, D. Mu, and A.R. Krainer. 2007. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 14:185-193. http://dx.doi.org/10.1038/nsmb1209
64. Kelemen, O., P. Convertini, Z. Zhang, Y. Wen, M. Shen, M. Falaleeva, and S. Stamm. 2013. Function of alternative splicing. Gene. 514:1-30. http://dx.doi.org/10.1016/j.gene.2012.07.083
65. Kfir, N., G. Lev-Maor, O. Glaich, A. Alajem, A. Datta, S.K. Sze, E. Meshorer, and G. Ast. 2015. SF3B1 association with chromatin determines splicing outcomes. Cell Reports. 11:618-629. http://dx.doi.org/10.1016/j.celrep.2015.03.048
66. Kim, E., J.O. Ilagan, Y. Liang, G.M. Daubner, S.C. Lee, A. Ramakrishnan, Y. Li, Y.R. Chung, J.B. Micol, M.E. Murphy, et al. 2015. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell. 27:617-630. http://dx.doi.org/10.1016/j.ccell.2015.04.006
67. Kim, H.J., N.C. Kim, Y.D. Wang, E.A. Scarborough, J. Moore, Z. Diaz, K.S. MacLea, B. Freibaum, S. Li, A. Molliex, et al. 2013. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 495:467-473. http://dx.doi.org/10.1038/nature11922
68. Koh, C.M., M. Bezzi, D.H. Low, W.X. Ang, S.X. Teo, F.P. Gay, M. Al-Haddawi, S.Y. Tan, M. Osato, A. Sabo, et al. 2015. MYC regulates the core premRNA splicing machinery as an essential step in lymphomagenesis. Nature. 523:96-100. http://dx.doi.org/10.1038/nature14351
69. Komeno, Y., Y.J. Huang, J. Qiu, L. Lin, Y. Xu, Y. Zhou, L. Chen, D.D. Monterroza, H. Li, R.C. DeKelver, et al. 2015. SRSF2 is essential for hematopoiesis, and its myelodysplastic syndrome-related mutations dysregulate alternative pre-mRNA splicing. Mol. Cell. Biol. 35:3071-3082. http://dx.doi.org/10.1128/MCB.00202-15
70. Kurtovic-Kozaric, A., B. Przychodzen, J. Singh, M.M. Konarska, M.J. Clemente, Z.K. Otrock, M. Nakashima, E.D. Hsi, K. Yoshida, Y. Shiraishi, et al. 2015. PRPF8 defects cause missplicing in myeloid malignancies. Leukemia. 29:126-136. http://dx.doi.org/10.1038/leu.2014.144
71. Lagier-Tourenne, C., M. Polymenidou, K.R. Hutt, A.Q. Vu, M. Baughn, S.C. Huelga, K.M. Clutario, S.C. Ling, T.Y. Liang, C. Mazur, et al. 2012. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15:1488-1497. http://dx.doi.org/10.1038/nn.3230
72. Lee, Y., and D.C. Rio. 2015. Mechanisms and regulation of alternative premRNA splicing. Annu. Rev. Biochem. 84:291-323. http://dx.doi.org/10.1146/annurev-biochem-060614-034316
73. Lee, Y.B., H.J. Chen, J.N. Peres, J. Gomez-Deza, J. Attig, M. Stalekar, C. Troakes, A.L. Nishimura, E.L. Scotter, C. Vance, et al. 2013. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Reports. 5:1178-1186. http://dx.doi.org/10.1016/j.celrep.2013.10.049
74. LeFave, C.V., M. Squatrito, S. Vorlova, G.L. Rocco, C.W. Brennan, E.C. Holland, Y.X. Pan, and L. Cartegni. 2011. Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. EMBO J. 30:4084-4097. http://dx.doi.org/10.1038/emboj.2011.259
75. Li, X., and J.L. Manley. 2005. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell. 122:365-378. http://dx.doi.org/10.1016/j.cell.2005.06.008
76. Li, Q., S. Zheng, A. Han, C.H. Lin, P. Stoilov, X.D. Fu, and D.L. Black. 2014. The splicing regulator PTBP2 controls a program of embryonic splicing required for neuronal maturation. eLife. 3:e01201. http://dx.doi.org/10.7554/eLife.01201
77. Li, X., T. Niu, and J.L. Manley. 2007. The RNA binding protein RNPS1 alleviates ASF/SF2 depletion-induced genomic instability. RNA. 13:2108-2115. http://dx.doi.org/10.1261/rna.734407
78. Li, Y.I., L. Sanchez-Pulido, W. Haerty, and C.P. Ponting. 2015. RBF OX and PTBP1 proteins regulate the alternative splicing of micro-exons in human brain transcripts. Genome Res. 25:1-13. http://dx.doi.org/10.1101/gr.181990.114
79. Licatalosi, D.D., M. Yano, J.J. Fak, A. Mele, S.E. Grabinski, C. Zhang, and R.B. Darnell. 2012. Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes Dev. 26:1626-1642. http://dx.doi.org/10.1101/gad.191338.112
80. Ling, J.P., O. Pletnikova, J.C. Troncoso, and P.C. Wong. 2015. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 349:650-655. http://dx.doi.org/10.1126/science.aab0983
81. Long, J.C., and J.F. Caceres. 2009. The SR protein family of splicing factors: Master regulators of gene expression. Biochem. J. 417:15-27. http://dx.doi.org/10.1042/BJ20081501
82. Love, J.E., E.J. Hayden, and T.T. Rohn. 2015. Alternative splicing in Alzheimer's disease. J. Parkinsons Dis. Alzheimers Dis. 2:6.
83. Luco, R.F., M. Allo, I.E. Schor, A.R. Kornblihtt, and T. Misteli. 2011. Epigenetics in alternative pre-mRNA splicing. Cell. 144:16-26. http://dx.doi.org/10.1016/j.cell.2010.11.056
84. Luo, J., N.L. Solimini, and S.J. Elledge. 2009. Principles of cancer therapy: Oncogene and non-oncogene addiction. Cell. 136:823-837. http://dx.doi.org/10.1016/j.cell.2009.02.024
85. Madan, V., D. Kanojia, J. Li, R. Okamoto, A. Sato-Otsubo, A. Kohlmann, M. Sanada, V. Grossmann, J. Sundaresan, Y. Shiraishi, et al. 2015. Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat. Commun. 6:6042. http://dx.doi.org/10.1038/ncomms7042
86. Maguire, S.L., A. Leonidou, P. Wai, C. Marchio, C.K. Ng, A. Sapino, A.V. Salomon, J.S. Reis-Filho, B. Weigelt, and R.C. Natrajan. 2015. SF3B1 mutations constitute a novel therapeutic target in breast cancer. J. Pathol. 235:571-580. http://dx.doi.org/10.1002/path.4483
87. Makishima, H., V. Visconte, H. Sakaguchi, A.M. Jankowska, S. Abu Kar, A. Jerez, B. Przychodzen, M. Bupathi, K. Guinta, M.G. Afable, et al. 2012. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood. 119:3203-3210. http://dx.doi.org/10.1182/blood-2011-12-399774
88. Massiello, A., J.R. Roesser, and C.E. Chalfant. 2006. SAP155 binds to ceramideresponsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA. FAS EB J. 20:1680-1682. http://dx.doi.org/10.1096/fj.05-5021fje
89. Matera, A.G., and Z. Wang. 2014. A day in the life of the spliceosome. Nat. Rev. Mol. Cell Biol. 15:108-121. http://dx.doi.org/10.1038/nrm3742
90. Matsunawa, M., R. Yamamoto, M. Sanada, A. Sato-Otsubo, Y. Shiozawa, K. Yoshida, M. Otsu, Y. Shiraishi, S. Miyano, K. Isono, et al. 2014. Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia. Leukemia. 28:1844-1850. http://dx.doi.org/10.1038/leu.2014.73
91. Matter, N., P. Herrlich, and H. Konig. 2002. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature. 420:691-695. http://dx.doi.org/10.1038/nature01153
92. Mirtschink, P., J. Krishnan, F. Grimm, A. Sarre, M. Horl, M. Kayikci, N. Fankhauser, Y. Christinat, C. Cortijo, O. Feehan, et al. 2015. HIFdriven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature. 522:444-449. http://dx.doi.org/10.1038/nature14508
93. Mykowska, A., K. Sobczak, M. Wojciechowska, P. Kozlowski, and W.J. Krzyzosiak. 2011. CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Res. 39:8938-8951. http://dx.doi.org/10.1093/nar/gkr608
94. Naftelberg, S., I.E. Schor, G. Ast, and A.R. Kornblihtt. 2015. Regulation of alternative splicing through coupling with transcription and chromatin structure. Annu. Rev. Biochem. 84:165-198. http://dx.doi.org/10.1146/annurev-biochem-060614-034242
95. Naro, C., and C. Sette. 2013. Phosphorylation-mediated regulation of alternative splicing in cancer. Int. J. Cell Biol. 2013:151839. http://dx.doi.org/10.1155/2013/151839
96. Naryshkin, N.A., M. Weetall, A. Dakka, J. Narasimhan, X. Zhao, Z. Feng, K.K. Ling, G.M. Karp, H. Qi, M.G. Woll, et al. 2014. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science. 345:688-693. http://dx.doi.org/10.1126/science.1250127
97. Nussbacher, J.K., R. Batra, C. Lagier-Tourenne, and G.W. Yeo. 2015. RNAbinding proteins in neurodegeneration: Seq and you shall receive. Trends Neurosci. 38:226-236. http://dx.doi.org/10.1016/j.tins.2015.02.003
98. O'Donovan, S.M., K. Hasselfeld, D. Bauer, M. Simmons, P. Roussos, V. Haroutunian, J.H. Meador-Woodruff, and R.E. McCullumsmith. 2015. Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia. Transl. Psychiatry. 5:e579. http://dx.doi.org/10.1038/tp.2015.74
99. Oldmeadow, C., D. Mossman, T.J. Evans, E.G. Holliday, P.A. Tooney, M.J. Cairns, J. Wu, V. Carr, J.R. Attia, and R.J. Scott. 2014. Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci. J. Psychiatr. Res. 52:44-49. http://dx.doi.org/10.1016/j.jpsychires.2014.01.011
100. Olshavsky, N.A., C.E. Comstock, M.J. Schiewer, M.A. Augello, T. Hyslop, C. Sette, J. Zhang, L.M. Parysek, and K.E. Knudsen. 2010. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene. Cancer Res. 70:3975-3984. http://dx.doi.org/10.1158/0008-5472.CAN-09-3468
101. Pacheco, T.R., L.F. Moita, A.Q. Gomes, N. Hacohen, and M. Carmo-Fonseca. 2006. RNA interference knockdown of hU2AF35 impairs cell cycle progression and modulates alternative splicing of Cdc25 transcripts. Mol. Biol. Cell. 17:4187-4199. http://dx.doi.org/10.1091/mbc. E06-01-0036
102. Pagliarini, V., C. Naro, and C. Sette. 2015. Splicing regulation: A molecular device to enhance cancer cell adaptation. BioMed Res. Int. 2015:543067. http://dx.doi.org/10.1155/2015/543067
103. Palacino, J., S.E. Swalley, C. Song, A.K. Cheung, L. Shu, X. Zhang, M. Van Hoosear, Y. Shin, D.N. Chin, C.G. Keller, et al. 2015. SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat. Chem. Biol. 11:511-517. http://dx.doi.org/10.1038/nchembio.1837
104. Papaemmanuil, E., M. Cazzola, J. Boultwood, L. Malcovati, P. Vyas, D. Bowen, A. Pellagatti, J.S. Wainscoat, E. Hellstrom-Lindberg, C. Gambacorti-Passerini, et al. 2011. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N. Engl. J. Med. 365:1384-1395. http://dx.doi.org/10.1056/NEJMoa1103283
105. Papasaikas, P., J.R. Tejedor, L. Vigevani, and J. Valcarcel. 2015. Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery. Mol. Cell. 57:7-22. http://dx.doi.org/10.1016/j.molcel.2014.10.030
106. Polymenidou, M., C. Lagier-Tourenne, K.R. Hutt, S.C. Huelga, J. Moran, T.Y. Liang, S.C. Ling, E. Sun, E. Wancewicz, C. Mazur, et al. 2011. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14:459-468. http://dx.doi.org/10.1038/nn.2779
107. Poulikakos, P.I., Y. Persaud, M. Janakiraman, X. Kong, C. Ng, G. Moriceau, H. Shi, M. Atefi, B. Titz, M.T. Gabay, et al. 2011. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature. 480:387-390. http://dx.doi.org/10.1038/nature10662
108. Poulos, M.G., R. Batra, K. Charizanis, and M.S. Swanson. 2011. Developments in RNA splicing and disease. Cold Spring Harb. Perspect. Biol. 3:a000778. http://dx.doi.org/10.1101/cshperspect.a000778
109. Prudencio, M., V.V. Belzil, R. Batra, C.A. Ross, T.F. Gendron, L.J. Pregent, M.E. Murray, K.K. Overstreet, A.E. Piazza-Johnston, P. Desaro, et al. 2015. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 18:1175-1182. http://dx.doi.org/10.1038/nn.4065
110. Przychodzen, B., A. Jerez, K. Guinta, M.A. Sekeres, R. Padgett, J.P. Maciejewski, and H. Makishima. 2013. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Blood. 122:999-1006. http://dx.doi.org/10.1182/blood-2013-01-480970
111. Quesada, V., L. Conde, N. Villamor, G.R. Ordonez, P. Jares, L. Bassaganyas, A.J. Ramsay, S. Bea, M. Pinyol, A. Martinez-Trillos, et al. 2011. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet. 44:47-52. http://dx.doi.org/10.1038/ng.1032
112. Quesnel-Vallières, M., M. Irimia, S.P. Cordes, and B.J. Blencowe. 2015. Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. Genes Dev. 29:746-759. http://dx.doi.org/10.1101/gad.256115.114
113. Raj, B., and B.J. Blencowe. 2015. Alternative splicing in the mammalian nervous system: Recent insights into mechanisms and functional roles. Neuron. 87:14-27. http://dx.doi.org/10.1016/j.neuron.2015.05.004
114. Ramos, A.D., R.E. Andersen, S.J. Liu, T.J. Nowakowski, S.J. Hong, C.C. Gertz, R.D. Salinas, H. Zarabi, A.R. Kriegstein, and D.A. Lim. 2015. The long noncoding RNA Pnky regulates neuronal differentiation of embryonic and postnatal neural stem cells. Cell Stem Cell. 16:439-447. http://dx.doi.org/10.1016/j.stem.2015.02.007
115. Roberts, T.C., K.V. Morris, and M.J. Wood. 2014. The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369:20130507.
116. Salton, M., W.K. Kasprzak, T. Voss, B.A. Shapiro, P.I. Poulikakos, and T. Misteli. 2015. Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing. Nat. Commun. 6:7103. http://dx.doi.org/10.1038/ncomms8103
117. Saltzman, A.L., Q. Pan, and B.J. Blencowe. 2011. Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev. 25:373-384. http://dx.doi.org/10.1101/gad.2004811
118. Sathasivam, K., A. Neueder, T.A. Gipson, C. Landles, A.C. Benjamin, M.K. Bondulich, D.L. Smith, R.L. Faull, R.A. Roos, D. Howland, et al. 2013. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl. Acad. Sci. USA. 110:2366-2370. http://dx.doi.org/10.1073/pnas.1221891110
119. Savage, K.I., J.J. Gorski, E.M. Barros, G.W. Irwin, L. Manti, A.J. Powell, A. Pellagatti, N. Lukashchuk, D.J. McCance, W.G. McCluggage, et al. 2014. Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability. Mol. Cell. 54:445-459. http://dx.doi.org/10.1016/j.molcel.2014.03.021
120. Scott, L.M., and V.I. Rebel. 2013. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors. J. Natl. Cancer Inst. 105:1540-1549. http://dx.doi.org/10.1093/jnci/djt257
121. Scotter, E.L., H.J. Chen, and C.E. Shaw. 2015. TDP-43 proteinopathy and ALS: Insights into disease mechanisms and therapeutic targets. Neurotherapeutics. 12:352-363. http://dx.doi.org/10.1007/s13311-015-0338-x
122. Sebestyén, E., M. Zawisza, and E. Eyras. 2015. Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer. Nucleic Acids Res. 43:1345-1356. http://dx.doi.org/10.1093/nar/gku1392
123. Sehgal, L., R. Mathur, F.K. Braun, J.F. Wise, Z. Berkova, S. Neelapu, L.W. Kwak, and F. Samaniego. 2014. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia. 28:2376-2387. http://dx.doi.org/10.1038/leu.2014.126
124. Shao, C., B. Yang, T. Wu, J. Huang, P. Tang, Y. Zhou, J. Zhou, J. Qiu, L. Jiang, H. Li, et al. 2014. Mechanisms for U2AF to define 3' splice sites and regulate alternative splicing in the human genome. Nat. Struct. Mol. Biol. 21:997-1005. http://dx.doi.org/10.1038/nsmb.2906
125. Shapiro, I.M., A.W. Cheng, N.C. Flytzanis, M. Balsamo, J.S. Condeelis, M.H. Oktay, C.B. Burge, and F.B. Gertler. 2011. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 7:e1002218. http://dx.doi.org/10.1371/journal.pgen.1002218
126. Shilo, Y., Z. Siegfried, and R. Karni. 2015. The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression. Mol. Cell. Oncol. 2:e970955. http://dx.doi.org/10.4161/23723548.2014.970955
127. Shirai, C.L., J.N. Ley, B.S. White, S. Kim, J. Tibbitts, J. Shao, M. Ndonwi, B. Wadugu, E.J. Duncavage, T. Okeyo-Owuor, et al. 2015. Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo. Cancer Cell. 27:631-643. http://dx.doi.org/10.1016/j.ccell.2015.04.008
128. Shkreta, L., and B. Chabot. 2015. The RNA splicing response to DNA damage. Biomolecules. 5:2935-2977. http://dx.doi.org/10.3390/biom5042935
129. Singh, R.K., and T.A. Cooper. 2012. Pre-mRNA splicing in disease and therapeutics. Trends Mol. Med. 18:472-482. http://dx.doi.org/10.1016/j.molmed.2012.06.006
130. Staropoli, J.F., H. Li, S.J. Chun, N. Allaire, P. Cullen, A. Thai, C.M. Fleet, Y. Hua, C.F. Bennett, A.R. Krainer, et al. 2015. Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7. Genomics. 105:220-228. http://dx.doi.org/10.1016/j.ygeno.2015.01.007
131. Sterne-Weiler, T., and J.R. Sanford. 2014. Exon identity crisis: Disease-causing mutations that disrupt the splicing code. Genome Biol. 15:201. http://dx.doi.org/10.1186/gb4150
132. Sveen, A., S. Kilpinen, A. Ruusulehto, R.A. Lothe, and R.I. Skotheim. 2015. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene. In press. http://dx.doi.org/10.1038/onc.2015.318
133. Tanackovic, G., A. Ransijn, P. Thibault, S. Abou Elela, R. Klinck, E.L. Berson, B. Chabot, and C. Rivolta. 2011. PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. Hum. Mol. Genet. 20:2116-2130. http://dx.doi.org/10.1093/hmg/ddr094
134. Tang, J.Y., J.C. Lee, M.F. Hou, C.L. Wang, C.C. Chen, H.W. Huang, and H.W. Chang. 2013. Alternative splicing for diseases, cancers, drugs, and databases. ScientificWorldJournal. 2013:703568. http://dx.doi.org/10.1155/2013/703568
135. Tejedor, J.R., P. Papasaikas, and J. Valcarcel. 2015. Genome-wide identification of Fas/CD95 alternative splicing regulators reveals links with iron homeostasis. Mol. Cell. 57:23-38. http://dx.doi.org/10.1016/j.molcel.2014.10.029
136. Tollervey, J.R., T. Curk, B. Rogelj, M. Briese, M. Cereda, M. Kayikci, J. Konig, T. Hortobagyi, A.L. Nishimura, V. Zupunski, et al. 2011. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14:452-458. http://dx.doi.org/10.1038/nn.2778
137. Tresini, M., D.O. Warmerdam, P. Kolovos, L. Snijder, M.G. Vrouwe, J.A. Demmers, W. van Ijcken, F.G. Grosveld, R.H. Medema, J.H. Hoeijmakers, et al. 2015. The core spliceosome as target and effector of non-canonical ATM signalling. Nature. 523:53-58. http://dx.doi.org/10.1038/nature14512
138. Tripathi, V., J.D. Ellis, Z. Shen, D.Y. Song, Q. Pan, A.T. Watt, S.M. Freier, C.F. Bennett, A. Sharma, P.A. Bubulya, et al. 2010. The nuclear-retained noncoding RNA MAL AT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell. 39:925-938. http://dx.doi.org/10.1016/j.molcel.2010.08.011
139. Turunen, J.J., E.H. Niemela, B. Verma, and M.J. Frilander. 2013. The significant other: Splicing by the minor spliceosome. Wiley Interdiscip. Rev. RNA. 4:61-76. http://dx.doi.org/10.1002/wrna.1141
140. Ule, J., A. Ule, J. Spencer, A. Williams, J.S. Hu, M. Cline, H. Wang, T. Clark, C. Fraser, M. Ruggiu, et al. 2005. Nova regulates brain-specific splicing to shape the synapse. Nat. Genet. 37:844-852. http://dx.doi.org/10.1038/ng1610
141. Valacca, C., S. Bonomi, E. Buratti, S. Pedrotti, F.E. Baralle, C. Sette, C. Ghigna, and G. Biamonti. 2010. Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J. Cell Biol. 191:87-99. http://dx.doi.org/10.1083/jcb.201001073
142. Vanharanta, S., C.B. Marney, W. Shu, M. Valiente, Y. Zou, A. Mele, R.B. Darnell, and J. Massague. 2014. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. eLife. 3:e02734.
143. Vaz-Drago, R., M.T. Pinheiro, S. Martins, F.J. Enguita, M. Carmo-Fonseca, and N. Custodio. 2015. Transcription-coupled RNA surveillance in human genetic diseases caused by splice site mutations. Hum. Mol. Genet. 24:2784-2795. http://dx.doi.org/10.1093/hmg/ddv039
144. Venables, J.P., R. Klinck, C. Koh, J. Gervais-Bird, A. Bramard, L. Inkel, M. Durand, S. Couture, U. Froehlich, E. Lapointe, et al. 2009. Cancerassociated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16:670-676. http://dx.doi.org/10.1038/nsmb.1608
145. Venables, J.P., J.P. Brosseau, G. Gadea, R. Klinck, P. Prinos, J.F. Beaulieu, E. Lapointe, M. Durand, P. Thibault, K. Tremblay, et al. 2013. RBF OX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol. Cell. Biol. 33:396-405. http://dx.doi.org/10.1128/MCB.01174-12
146. Visconte, V., H.J. Rogers, J. Singh, J. Barnard, M. Bupathi, F. Traina, J. McMahon, H. Makishima, H. Szpurka, A. Jankowska, et al. 2012. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood. 120:3173-3186. http://dx.doi.org/10.1182/blood-2012-05-430876
147. Voineagu, I., X. Wang, P. Johnston, J.K. Lowe, Y. Tian, S. Horvath, J. Mill, R.M. Cantor, B.J. Blencowe, and D.H. Geschwind. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 474:380-384. http://dx.doi.org/10.1038/nature10110
148. Wahl, M.C., C.L. Will, and R. Luhrmann. 2009. The spliceosome: Design principles of a dynamic RNP machine. Cell. 136:701-718. http://dx.doi.org/10.1016/j.cell.2009.02.009
149. Walter, M.J., L. Ding, D. Shen, J. Shao, M. Grillot, M. McLellan, R. Fulton, H. Schmidt, J. Kalicki-Veizer, M. O'Laughlin, et al. 2011. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia. 25:1153-1158. http://dx.doi.org/10.1038/leu.2011.44
150. Wang, C., G. Sashida, A. Saraya, R. Ishiga, S. Koide, M. Oshima, K. Isono, H. Koseki, and A. Iwama. 2014a. Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia. Blood. 123:3336-3343. http://dx.doi.org/10.1182/blood-2013-12-544544
151. Wang, G., Z. Li, Q. Zhao, Y. Zhu, C. Zhao, X. Li, Z. Ma, X. Li, and Y. Zhang. 2014b. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway. Oncol. Rep. 31:1839-1845.
152. Wang, J., J. Zhang, K. Li, W. Zhao, and Q. Cui. 2012. SpliceDisease database: Linking RNA splicing and disease. Nucleic Acids Res. 40(D1):D1055-D1059. http://dx.doi.org/10.1093/nar/gkr1171
153. Weyn-Vanhentenryck, S.M., A. Mele, Q. Yan, S. Sun, N. Farny, Z. Zhang, C. Xue, M. Herre, P.A. Silver, M.Q. Zhang, et al. 2014. HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism. Cell Reports. 6:1139-1152. http://dx.doi.org/10.1016/j.celrep.2014.02.005
154. Wickramasinghe, V.O., M. Gonzalez-Porta, D. Perera, A.R. Bartolozzi, C.R. Sibley, M. Hallegger, J. Ule, J.C. Marioni, and A.R. Venkitaraman. 2015. Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5' splice site strength. Genome Biol. 16:201. http://dx.doi.org/10.1186/s13059-015-0749-3
155. Xiong, H.Y., B. Alipanahi, L.J. Lee, H. Bretschneider, D. Merico, R.K. Yuen, Y. Hua, S. Gueroussov, H.S. Najafabadi, T.R. Hughes, et al. 2015. The human splicing code reveals new insights into the genetic determinants of disease. Science. 347:1254806. http://dx.doi.org/10.1126/science.1254806
156. Xu, Y., X.D. Gao, J.H. Lee, H. Huang, H. Tan, J. Ahn, L.M. Reinke, M.E. Peter, Y. Feng, D. Gius, et al. 2014. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing. Genes Dev. 28:1191-1203. http://dx.doi.org/10.1101/gad.241968.114
157. Yang, J., and R.A. Weinberg. 2008. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev. Cell. 14:818-829. http://dx.doi.org/10.1016/j.devcel.2008.05.009
158. Yang, C., H. Wang, T. Qiao, B. Yang, L. Aliaga, L. Qiu, W. Tan, J. Salameh, D.M. McKenna-Yasek, T. Smith, et al. 2014a. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 111:E1121-E1129. http://dx.doi.org/10.1073/pnas.1322641111
159. Yang, J., B.D. Bennett, S. Luo, K. Inoue, S.A. Grimm, G.P. Schroth, P.R. Bushel, H.K. Kinyamu, and T.K. Archer. 2015. LIN28A modulates splicing and gene expression programs in breast cancer cells. Mol. Cell. Biol. 35:3225-3243. http://dx.doi.org/10.1128/MCB.00426-15
160. Yang, Y., L. Han, Y. Yuan, J. Li, N. Hei, and H. Liang. 2014b. Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types. Nat. Commun. 5:3231.
161. Yin, X., N. Jin, J. Gu, J. Shi, J. Zhou, C.X. Gong, K. Iqbal, I. Grundke-Iqbal, and F. Liu. 2012. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion. J. Biol. Chem. 287:30497-30506. http://dx.doi.org/10.1074/jbc. M112.355412
162. Yoshida, K., M. Sanada, Y. Shiraishi, D. Nowak, Y. Nagata, R. Yamamoto, Y. Sato, A. Sato-Otsubo, A. Kon, M. Nagasaki, et al. 2011. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 478:64-69. http://dx.doi.org/10.1038/nature10496
163. Yu, Y., and R. Reed. 2015. FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP. Proc. Natl. Acad. Sci. USA. 112:8608-8613. http://dx.doi.org/10.1073/pnas.1506282112
164. Yu, Y., B. Chi, W. Xia, J. Gangopadhyay, T. Yamazaki, M.E. Winkelbauer-Hurt, S. Yin, Y. Eliasse, E. Adams, C.E. Shaw, and R. Reed. 2015. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish. Nucleic Acids Res. 43:3208-3218. http://dx.doi.org/10.1093/nar/gkv157
165. Zhang, C., and G. Peng. 2015. Non-coding RNAs: An emerging player in DNA damage response. Mutat. Res. Rev. Mutat. Res. 763:202-211. http://dx.doi.org/10.1016/j.mrrev.2014.11.003
166. Zhang, J., and J.L. Manley. 2013. Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov. 3:1228-1237. http://dx.doi.org/10.1158/2159-8290.CD-13-0253
167. Zhang, C., M.A. Frias, A. Mele, M. Ruggiu, T. Eom, C.B. Marney, H. Wang, D.D. Licatalosi, J.J. Fak, and R.B. Darnell. 2010. Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Science. 329:439-443. http://dx.doi.org/10.1126/science.1191150
168. Zhang, J., Y.K. Lieu, A.M. Ali, A. Penson, K.S. Reggio, R. Rabadan, A. Raza, S. Mukherjee, and J.L. Manley. 2015a. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proc. Natl. Acad. Sci. USA. 112:E4726-E4734. http://dx.doi.org/10.1073/pnas.1514105112
169. Zhang, K., C.J. Donnelly, A.R. Haeusler, J.C. Grima, J.B. Machamer, P. Steinwald, E.L. Daley, S.J. Miller, K.M. Cunningham, S. Vidensky, et al. 2015b. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 525:56-61. http://dx.doi.org/10.1038/nature14973
170. Zhang, Z., F. Lotti, K. Dittmar, I. Younis, L. Wan, M. Kasim, and G. Dreyfuss. 2008. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell. 133:585-600. http://dx.doi.org/10.1016/j.cell.2008.03.031
171. Zhang, Z., A.M. Pinto, L. Wan, W. Wang, M.G. Berg, I. Oliva, L.N. Singh, C. Dengler, Z. Wei, and G. Dreyfuss. 2013. Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. Proc. Natl. Acad. Sci. USA. 110:19348-19353. http://dx.doi.org/10.1073/pnas.1319280110
172. Zhou, H.L., G. Luo, J.A. Wise, and H. Lou. 2014a. Regulation of alternative splicing by local histone modifications: Potential roles for RNA-guided mechanisms. Nucleic Acids Res. 42:701-713. http://dx.doi.org/10.1093/nar/gkt875
173. Zhou, T., P. Hasty, C.A. Walter, A.J. Bishop, L.M. Scott, and V.I. Rebel. 2013. Myelodysplastic syndrome: An inability to appropriately respond to damaged DNA? Exp. Hematol. 41:665-674. http://dx.doi.org/10.1016/j.exphem.2013.04.008
174. Zhou, X., X. Li, Y. Cheng, W. Wu, Z. Xie, Q. Xi, J. Han, G. Wu, J. Fang, and Y. Feng. 2014b. BCL AF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells. Nat. Commun. 5:4581. http://dx.doi.org/10.1038/ncomms5581